loader2
Partner With Us NRI

Emami Ltd share Price

Company details

512.35
529.35
340.55
583.25
6M Return 49.93%
1Y Return 2.45%
Mkt Cap.(Cr) 22,711.41
Volume 165,545
Div Yield 1.54%
OI
-
OI Chg %
-
Volume 165,545

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Personal products company Emami announced Q1FY24 results:

  • Consolidated revenues at Rs 826 crore grew by 7%
    • Domestic business grew by 7%
    • International business grew by 8% (Constant currency growth of 11%)
  • Gross margins at 65.4% improved by 240 bps
  • EBIDTA at Rs 190 crore grew by 10%
    • EBIDTA margins improved by 60 bps
  • Profit after tax at Rs 138 crore grew by 87%
    • PAT margins improved by 720 bps
  • Completed buyback of shares amounting to Rs 185.3 crore (excl. brokerage, taxes & levies).

Harsha V Agarwal, Vice-Chairman and Managing Director, Emami said, “We are happy to report a 7% growth in domestic business despite challenging operating environment. While erratic summer & unseasonal rains impacted summer product offtakes, our non-summer portfolio grew strongly by 16%. International business also continued its growth trajectory with 11% constant currency growth. With inflation moderating further, we look to the future with increased optimism and confidence. With the development of the digital eco-system, both e-commerce and D2C will play a key role in the organization’s growth and we will continue to invest in strengthening our presence in an omnichannel presence to reach our consumers.”

Mohan Goenka, Vice Chairman and Whole-Time Director, Emami said, “The quarter witnessed strong performance by our Pain Management, BoroPlus, and Healthcare range which grew in double digits, with Dermicool posting a high single-digit growth. Backed by our resilient and competitive performance and aided by softening of input cost, we could deliver a healthy expansion of gross margin and EBIDTA and a robust profit growth of 87%. All our channels, especially Modern Trade eCommerce continued to perform well and contributed 9.7% each to domestic business, a growth of 45% and 47% respectively over the previous year. We endeavor to strengthen our core and continue to invest in growth drivers to deliver healthy profitability this year.”

 

Result PDF

View Other Company Results

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Emami Ltd Stocks COMPARISION

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 2,302.80 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 13,565.29 -8,591.81
LAST 3M 37,244.98 3,231.65
LAST 6M 45,909.21 154,115.29
LAST 12M 133,371.71 158,810.39

Emami Ltd Information

Stock PE (TTM)
32.52
Promoter Holding
54.52%
Book Value
52.1999
ROCE
27.9%
ROE
28.65%
Description
  • Emami Ltd. is one of India’s leading and fastest-growing personal and healthcare businesses. Its portfolio includes household brands, such as BoroPlus, Fair and Handsome, Mentho Plus Balm, Navratna, Kesh King, Fast Relief, and Zandu Balm. It was established in 1974, with its headquarters in Kolkata, West Bengal. During FY 2021-2022, the company’s total revenue was Rs 3,287.28 crore, up 11.40% against Rs 2,950.80 in the previous financial year, 2020-2021. On 21 October 2022, the company’s market capitalisation stood at Rs 21,135 crore.

    Emami Ltd.’s share is listed on the Bombay Stock Exchange with the code 531162, and on the National Stock Exchange with the code EMAMILTD.

    The company’s product portfolio comprises over 300 products based on ayurvedic formulations. Its operations are spread across 60 countries, including SEA, MENAP, SAARC, Eastern Europe, CIS, and African countries. In 2022, Emami Ltd. acquired Dermicool, one of India’s leading prickly heat and cool talc brands.

    The company’s shareholding pattern on 30 September 2022 showed a 54.27% promoter stake, 11.25% FII stake, 27.02% DII stake, and 7.47% public stake. The leading promoter was Suraj Finvest, with a 23.96% share. In the June 2022 quarter, promoters unpledged 3.77% of shares, bringing the total pledge to 33.37% of promoter holdings.

    Mr R S Agarwal is the company’s founder and chairman emeritus. The other members of the management team include Mr N H Bhansali, Mr A K Joshi, Mr Vivek Dhir, Mr Gul Raj Bhatia, Ms Punita Kalra, Mr Dhiraj Agarwal, Mr Chandra Kant Katiyar, Mr Tuhin Biswas, and Mr Vinod Rao. Its auditors include S R Batliboi & Co. LLP. As of 30 September 2022, the company’s total number of outstanding shares was 44.12 crores.

    On 21 October 2022, the company’s share price closed at Rs 477.15 on BSE, while on NSE, it closed at Rs 479.10. The 52-week high price for Emami Ltd.’s share was Rs 578.50, and the 52-week low price was Rs 393.40. The share’s one-year return was -10.30%, and the six-month return was 0.07%.

    As of September 2022, L&T Midcap Fund had a 4.04% stake in the company. DSP Midcap Fund had a 2.98% stake, Mirae Asset Emerging Bluechip Fund had a 2.03% stake, and Kotak Emerging Equity Fund had a 1.33% stake.


    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.

No Data Found

AGM Date (Month) : Aug
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 531162
NSE Code : EMAMILTD
Book Closure Date (Month) :
BSE Group : A
ISIN : INE548C01032

FAQ’s on Emami Ltd Shares

You can buy Emami Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Emami Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Sep 22, 2023 03:59 PM the closing price of Emami Ltd was ₹ 517.25.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Sep 22, 2023 03:59 PM, the market cap of Emami Ltd stood at ₹ 22,711.41.

The latest PE ratio of Emami Ltd as of Sep 22, 2023 03:59 PM is 32.52

The latest PB ratio of Emami Ltd as of Sep 22, 2023 03:59 PM is 0.10

The 52-week high of Emami Ltd is ₹ 583.25 while the 52-week low is ₹ 340.55

Download Our App

market app
market app